SKI Market

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

394.8213477

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

37.92

98803.89

EPS(TTM)

Face Value()

Div & Yield %

45.29

0.24

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	11171.72	10933.30	10645.64	8457.00	11287.14	15823.68
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	11171.72	10933.30	10645.64	8457.00	11287.14	15823.68
Other Income	587.53	328.12	670.10	443.92	670.99	589.86
Stock Adjustments	-46.55	67.66	116.23	263.95	-45.51	-2.99
Total Income	11712.70	11329.08	11431.97	9164.87	11912.62	16410.55
EXPENDITURE :
Raw Materials	5311.58	5675.34	5964.48	4755.95	5800.74	7241.83
Power & Fuel Cost	174.82	185.59	191.58	167.86	477.99	512.34
Employee Cost	1161.15	1063.07	980.56	890.53	1600.04	1735.42
Other Manufacturing Expenses	421.52	426.63	414.51	328.42	705.68	925.86
Selling & Administrative Expenses	873.42	960.27	822.21	939.38	1009.36	1069.84
Miscellaneous Expenses	108.12	132.49	164.49	148.96	249.13	215.57
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	8050.61	8443.39	8537.83	7231.10	9842.94	11700.86
Operating Profit	3662.09	2885.69	2894.14	1933.77	2069.68	4709.69
Interest	213.15	230.04	182.60	74.58	16.94	28.68
Gross Profit	3448.94	2655.65	2711.54	1859.19	2052.74	4681.01
Depreciation	285.36	297.20	254.58	243.26	415.26	488.00
Profit Before Tax	3163.58	2358.45	2456.96	1615.93	1637.48	4193.01
Tax	746.82	627.37	598.08	412.16	379.70	1043.34
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	1.96	-15.71	-95.26	-23.34	-196.93	36.76
Reported Net Profit	2414.80	1746.79	1954.14	1227.11	1454.71	3112.91
Extraordinary Items	-11.93	9.46	3.28	9.94	-81.27	-0.13
Adjusted Net Profit	2426.73	1737.33	1950.86	1217.17	1535.98	3113.04
Adjustment below Net Profit	1.08	-5.26	-1.69	8.28	1.69	-6.42
P & L Balance brought forward	20090.40	18348.87	16660.08	15864.14	14671.41	11799.30
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	232.30	0.00	263.66	439.45	263.67	234.38
P & L Balance carried down	22273.98	20090.40	18348.87	16660.08	15864.14	14671.41
Dividend	232.30	0.00	263.66	439.45	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	400.00	0.00	450.00	750.00	900.00	400.00
Dividend Per Share(Rs)	4.00	0.00	4.50	7.50	9.00	4.00
Earnings Per Share-Unit Curr	41.58	30.08	33.35	20.94	24.83	53.13
Earnings Per Share(Adj)-Unit Curr	41.58	30.08	33.35	20.94	24.83	53.13
Book Value-Unit Curr	391.14	353.55	336.62	307.80	292.15	271.80
Book Value(Adj)-Unit Curr	391.14	353.55	336.62	307.80	292.15	271.80

74,708.79 -150.20
( -0.20%)

52,073.35 369.71
(0.72%)

7,785.28 113.78
(1.48%)

65,040.24 903.99
(1.41%)

10,737.46 78.33
(0.73%)

95.99 0.12
(0.12%)

110.24 0.24
(0.22%)

128.54 0.36
(0.28%)

0.61 0.00
(-0.53%)

EQUITY - MARKET SCREENER

Imp documents

74,708.79 -150.20 ( -0.20%)

52,073.35 369.71 (0.72%)

7,785.28 113.78 (1.48%)

65,040.24 903.99 (1.41%)

10,737.46 78.33 (0.73%)

95.99 0.12 (0.12%)

110.24 0.24 (0.22%)

128.54 0.36 (0.28%)

0.61 0.00 (-0.53%)

EQUITY - MARKET SCREENER

74,708.79 -150.20
( -0.20%)

52,073.35 369.71
(0.72%)

7,785.28 113.78
(1.48%)

65,040.24 903.99
(1.41%)

10,737.46 78.33
(0.73%)

95.99 0.12
(0.12%)

110.24 0.24
(0.22%)

128.54 0.36
(0.28%)

0.61 0.00
(-0.53%)